Changes at FDA, HHS Ranked No.1 Development, Survey Finds | MHE 2025 Pharmacy Survey, Part 1
The survey was conducted from March 10 through April 9, when the Department of Government Efficiency was in news
Will the Trump Administration Advantage Medicare Advantage?
Multiple Myeloma Treatment: The Price of Success
The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of treatment high.
Healthcare Nirvana: Fewer Insurance Coverage Hassles
Nirvana, a healthcare technology startup, uses artificial intelligence to better predict insurance coverage.
Alternatives to Opioids For Pain Management
Agents that target NaV1.8, a voltage-gated sodium channel, are showing promise. The FDA approved one of them, Journavx (suzetrigine) in January 2025.
